Mindfulness for central serous chorioretinopathy
Part of Eyes & vision clinical trials.
This study is testing whether mindfulness-based stress reduction can help people with central serous chorioretinopathy (CSCR), a condition causing fluid buildup under the retina. If you have active CSCR that started recently, you might be eligible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have active central serous chorioretinopathy (CSCR) with fluid in the central retina on OCT.
- You have changes in the retinal pigment epithelium (RPE) seen on imaging.
- Your current episode started less than 6 months ago.
- You have not had laser treatment (including PDT) for CSCR in the study eye.
- You have not used steroid or carbonic anhydrase inhibitor eye drops in the last 90 days.
- You have not had injections into the eye (anti-VEGF or steroid) in the last 180 days.
- You have not had eye surgery or laser in the last 90 days.
- You do not have other retinal diseases that could cause fluid, such as diabetic retinopathy or macular degeneration.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the link between gut bacteria and central serous chorioretinopathy (CSC), a condition where fluid builds up under the retina. It may help us understand why some people get CSC and find better ways to treat it.
This study measures blood flow in the eye in people with acute or chronic central serous chorioretinopathy (CSC). It uses eye scans and special imaging to better understand what’s happening and whether it may differ between short-term and long-term disease.
This trial tests a low-energy “subthreshold” laser to treat long-lasting fluid under the retina from central serous chorioretinopathy (CSCR). It may help dry up the fluid and improve vision, compared with a sham (placebo) treatment.
This study tests a gentle laser treatment called micropulse laser for people with chronic central serous chorioretinopathy. It aims to help dry up the fluid under the retina that has not responded to standard medications for at least 6 months.
This trial tests whether taking oral melatonin (a natural hormone) can help treat central serous chorioretinopathy, a condition where fluid builds up under the retina and blurs vision. It may be a good fit if you were recently diagnosed and haven't had certain eye procedures recently.
This trial compares two treatments for chronic central serous chorioretinopathy (CSC), a condition that causes fluid buildup under the retina. It tests whether adding a light therapy (photodynamic therapy) to micropulse laser treatment helps improve vision more than laser alone.
Hear when a new Central Serous Chorioretinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.